2017 Fast Lane Honoree NuvOx Pharma
The Human Brain is our most complex organ. Everything we are and everything we do is controlled by our brain. NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing an innovative nanotechnology for oxygen delivery to treat life-threatening diseases where hypoxia plays a role like cancer, stroke, sickle cell disease, hemorrhagic shock, traumatic brain injury, and heart attack. Hypoxia is when there is a deficiency in the amount of oxygen reaching the tissues. NuvOx is currently in clinical trials for brain cancer and stroke.
Lightworks Algae Energy ASU Research
AZBio and SynCardia on ABC15
By: Christina Estes ABC15
Tucson-based SynCardia Systems was among the companies showcased at the annual AZ Bio Expo.It’s a chance for bioscience and technology companies to learn more about funding opportunities and hear success stories.According to the Arizona BioIndustry Association, our state is getting more federal funding for research and seeing higher job growth in the bioscience industry compared to the national average.“Tucson and Arizona are the international headquarters for the world’s only total artificial heart,” said Don Isaacs, SynCardia vice president of communications. “They replace the exact same parts of the heart as if you had a heart transplant.”The SynCardia heart is made in Arizona using bio-compatible material also made here. Isaacs says they have 82 employees in Arizona and about 80 people currently using the heart. The device is considered a bridge for people awaiting a transplant or a life saver for those who will not get transplants due to age or medical conditions.“There’s only 2,200 hearts available per year in the United States and the level of donors has been the same for the last twenty years,” Isaacs said.SynCardia is also undergoing FDA clinical trials for the world’s first wearable power supply for their temporary artificial heart.
(Republished with permission from ABC15)
Read more: http://www.abc15.com/dpp/news/region_southeast_valley/tempe/Arizona-company-SynCardia-Systems-makes-worlds-first-total-temporary-artificial-heart#ixzz2X99ewU3x
Biotech TGen Alzheimers Disease Research
The Translational Genomics Research Institute (TGen) is a Phoenix-based nonprofit working with collaborators in the scientific and medical communities to improve the efficiency and effectiveness of gene research, fighting diseases such as cancer, neurological disorders and diabetes. This video features researchers Matthew Huentelman and Travis Dunkley, as well as a few patients.
DNA Sequencing and Disease Diagnosis
Northern Arizona University's Paul Keim describes how automated technology and robotics are used to analyze thousands of samples of DNA at one time. He explains the human genome and the information contained in DNA. Keim believes researching the DNA of disease causing organisms will advance disease treatment. Northern Arizona University is home to one of the largest pathogen related genomics research centers in the world. Read the article Genomic Research>>
Phoenix Biomedical Campus: Health Sciences Education Building
Tour the newest addition to the Phoenix Biomedical Campus - the Health Sciences Education Building. This spectacular copper-faced structure will play a critical role in the education of the next generation of science and health professionals. The 268,000 square-foot building is home to the University of Arizona and Northern Arizona University health sciences programs.
Nasseo moves into the Fast Lane
Nasseo, Inc. is a start-up medical device company developing an implant surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. Over the past 18 months the company has achieved very impressive milestones and is in the Fast Lane to delivering a new platform technology that benefits patients in several compelling markets.
In 2013 NASSEO was accepted into the BioInspire Medical Device accelerator in Peoria, AZ. In addition to mentoring and support, NASSEO received a $300,000 investment of seed funding from the highly competitive program. NASSEO was also named the 2013 Innovation Challenge Winner by the Arizona Commerce Authority (ACA) in its spring Arizona Innovation Challenge securing $250,000 for the commercialization of its first product, the TiArray™ Dental Implant which received FDA approval in 2013.